| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b444727238e22af49307e59b3bdd3c47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd8c629a663b5200bf58a3bac1194c34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ce0e9bdd1beef9f8589e9c59fafe2f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-702 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 |
| filingDate |
2012-03-23^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c28147ee7d32e102529ec34fafdeaead
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4195e2f2eeb64086fdda26f28d51d9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c4010fe39c598f9227f8b945222910 |
| publicationDate |
2014-01-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014010839-A1 |
| titleOfInvention |
Method of screening antiretroviral compounds and vaccine |
| abstract |
The present invention relates to an in vitro method of screening for candidate compounds capable of being used for the preventative and/or curative treatment of a disease caused by a retrovirus in which the candidate compound which modulates the expression and/or the activity of the SAMHD1 protein is identified as a candidate compound capable of being used for the preventative and/or curative treatment of a disease caused by a retrovirus. n The invention also relates to a vaccine composition and an immunogenic composition, comprising i) an inhibitor of the expression and/or of the activity of the SAMHD1 protein and ii) at least one antigen of a retrovirus. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352623-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019175415-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021188840-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649442-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11193123-B2 |
| priorityDate |
2011-03-23^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |